Subscribe to DSC Newsletter

Kevin A'court's Blog (1)

2.5 Quintillion Reasons to use Real World Evidence

NEHI puts a price on patients not adhering to treatment. It’s $290 Billion worth of a new problem for the pharmaceuticals industry – getting beyond the pill to influence the behaviours or patients and thereby influence the outcomes on which their reimbursements, and ultimately profitability, depends. Investment in patient access and adherence technology and programs is set to increase exponentially over the next five years, but if this investment is going to pay off, the data strategy to…

Continue

Added by Kevin A'court on April 28, 2016 at 12:00am — No Comments

Videos

  • Add Videos
  • View All

© 2019   Data Science Central ®   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service